ClinicalTrials.Veeva

Menu

FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Acute Bronchiolitis

Study type

Observational

Funder types

Other

Identifiers

NCT02093715
TASMC-13-YS-07-075-CTIL

Details and patient eligibility

About

The purpose of this study is to determine Fractional exhaled Nitric-Oxide (FeNO)levels and blood cytokines during acute bronchiolitis, and to seek for correlation between these markers and future development of asthma.

Enrollment

400 estimated patients

Sex

All

Ages

2 weeks to 2 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • First episode of shortness of breath
  • Children in ages 2 weeks to 2 years

Exclusion criteria

  • Any chronic disease
  • Congenital anomalies

Trial design

400 participants in 5 patient groups

RSV
Description:
Infant with acute bronchiolitis due to RSV
Co- Infection
Description:
Infant with acute bronchiolitis due to RSV and other respiratory virus
Other
Description:
Infant with acute bronchiolitis due to non-RSV respiratory virus
Unknown
Description:
Infant with acute bronchiolitis with negative PCR results for respiratory viruses
Control
Description:
Healthy infants

Trial contacts and locations

1

Loading...

Central trial contact

Yakov Sivan, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems